Declining Expression of Neprilysin in Alzheimer Disease Vasculature: Possible Involvement in Cerebral Amyloid Angiopathy
Open Access
- 1 October 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 61 (10) , 849-856
- https://doi.org/10.1093/jnen/61.10.849
Abstract
Molecular, genetic, and pharmacological studies have shown that neprilysin (also called NEP) catabolizes amyloid β peptides (Aβ) in healthy conditions. However, in Alzheimer disease (AD), Aβ accumulates forming senile plaques in brain parenchyma and amyloid deposition around blood vessels. In this study, we tested at cellular level the relationship between neprilysin and Aβ in human healthy and AD brain. Our results provided evidence for declining levels of neprilysin in AD brains as compared to healthy controls in parallel with increasing deposition of Aβ. In hippocampus of AD individuals we observed a significant down-regulation of neprilysin expression in pyramidal neurons, consistent with the possibility that neprilysin controls the level of Aβ accumulation and plaque formation in this area. In the cortex and leptomeninges, neprilysin was expressed in the smooth muscle cells of blood vessels. In sections from AD patients we observed a clear inverse relationship between neprilysin and Aβ peptide levels in the vasculature, implicating neprilysin in cerebral amyloid angiopathy.Keywords
This publication has 20 references indexed in Scilit:
- Metabolic Regulation of Brain Aβ by NeprilysinScience, 2001
- Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptideNeuroscience Letters, 2001
- Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human BrainJournal of Neurochemistry, 2000
- Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular Aβ ClearanceAnnals of the New York Academy of Sciences, 2000
- Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological depositionNature Medicine, 2000
- Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloidProceedings of the National Academy of Sciences, 1999
- The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's diseaseTrends in Cell Biology, 1998
- The Pathogenesis of Senile PlaquesJournal of Neuropathology and Experimental Neurology, 1997
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995
- Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderlyJournal of the Neurological Sciences, 1993